RELIEF Project: One of the 50 Best Digital Ideas

The RELIEF project, led by BravoSolution Spain, whose objective is to search for new technologies that improve the self-management of chronic pain patients, has been awarded as one of the 50 Best Digital Ideas in 2016, bestowed by leading Spanish financial daily Expansión, in the Digital Institutions category. RELIEF is a Pre-Commercial procurement project co-funded by the European Commission under the Horizon 2020 programme. The project, started in February 2016, has a consortium consisting of research institutions, consultancies and public sector organizations: Servicio Andaluz de Salud (SAS) and the PSiNET research group of the Universitat Oberta de Catalunya (UOC), from Spain; the Réseau des Acheteurs Hospitaliers d’Île de France (RESAH IDF) and the SPH Conseil (Public Health Care Consulting) from France; and the Uppsala County Council - CCU from Sweden.

The new technologies and solutions are sought by using a Pre-Commercial Procurement (PCP) process. Pre-Commercial Procurement is a mechanism for procuring R&D services with the purpose of developing a new product or solution that solve the common challenge of the project: how to improve self-management of chronic pain patients with technology? A PCP process typically consists of three phases: concept/solution design, prototype development and pilot phase (development of first pre-products on a small scale that are tested in the field).

PCP is about stimulating supplier product development from the demand side so that from the outset it fits perfectly to the needs of the public authority interested in deploying the service commercially. It is about the public and private sector sharing the risks and benefits of picking up exploratory research which has the potential to innovate public services from the early stages of pre-commercial product development up to the stage where products are ready for commercialization.

In preparation of the PCP call for tender, an Open Market Consultation (OMC) with potential tenderers and end-users is being held to broach the views of the market about RELIEF project's scope. The purpose of the OMC is to canvass wide stakeholder opinion on the suitability of RELIEF PCP. The OMC will be an essential part of the preparation of the PCP Challenge. With the market consultation, the consortium will get an insight into the market; the state of the art and future developments in order to prepare an adequate procurement with the right and feasible scope.

In order to gain this knowledge, companies in the EU are invited to fill in an online questionnaire on the RELIEF PCP Challenge. The OPC questionnaire is published here http://relief-chronicpain.eu/marketConsultation.html. The output of the OMC will give a broad insight into the current state of the art of the RELIEF proposed system. It will allow contributors to give feedback on what technologies should be included in RELIEF, where they see the biggest technical challenges and what should be shared. The results of the consultations will be fully documented and taken into account in order to detail the tender specifications.

For further information about RELIEF project, please visit:
http://relief-chronicpain.eu/index.html

About BravoSolution
BravoSolution is a leading global strategic procurement solution provider. Our procurement technology platform and practitioner experience help more than 600 companies and over 100,000 procurement professionals in over 70 countries unlock the power of procurement to drive financial performance, develop procurement organisational excellence, manage risk and influence innovation.

BravoSolution's approach to strategic procurement consistently delivers business outcomes to enable customers to outperform their performance objectives. BravoSolution has direct operations in 18 offices located in 12 countries across 4 continents, employing more than 600 procurement experts.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...